Global Hemp Group Inc.
GHG.CN
Canadian Securities Exchange0.02
CAD
-0.01
- -
Global Hemp Group Inc.
GHG.CN
(Canadian Securities Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Global Hemp Group Inc. specializes in industrial hemp and biopharma sectors, producing a diverse range of hemp-based products and solutions with an emphasis on environmental sustainability and health innovation. The company’s industrial hemp division focuses on environmentally friendly applications including hemp for construction materials, sustainable bio-energy sources, bio-composites, textiles, non-woven items, and hemp fiber products, all contributing to a carbon-negative footprint. Its biopharma division is dedicated to health and wellness products through exclusive licensing of patents and intellectual property involving cannabinoids and natural biologics like functional mushrooms, targeting pharmaceutical and nutraceutical markets. Founded in 2014 and headquartered in Vancouver, British Columbia, Global Hemp Group operates in Canada and the United States, with cultivation projects in New Brunswick and Oregon and a Hemp Agro-Industrial Zone (HAIZ) in Colorado serving as a hub for production, research, and commercial applications. The company has recently advanced its vertical integration by executing an amended exclusive option agreement to acquire Serres Thériault (2021) Inc., a vertically integrated cannabis operator in New Brunswick with licensed facilities for cannabis micro-processing, a farmgate retail store, research and development, and hemp cultivation focused on cannabinoid extraction, particularly CBG. Recent major developments include acquiring a 50% stake in the Oregon Hemp Project, enabling full consolidation of a 109-acre farm focused on hemp cultivation and cannabinoid extraction, and securing short-term financing through private placements and debt settlements. Additionally, Global Hemp Group expanded its biopharma portfolio by acquiring exclusive licenses and key patents from Apollon Formularies plc, a UK-based pharmaceutical company specializing in cancer treatments derived from natural biologics, as well as forming strategic alliances for the commercialization of bioactive lipid agent technologies that enhance drug bioavailability. These strategic moves strengthen GHG’s operational capacity and expand its footprint in both industrial hemp and biopharma segments across North America and Europe. Global Hemp Group employs an integrated modular approach to hemp cultivation, processing, and marketing, focusing on sustainability, innovation, and social responsibility to serve markets in construction, automotive, pharmaceuticals, nutraceuticals, and wellness industries. This comprehensive approach and recent strategic acquisitions position Global Hemp Group as a vertically integrated leader in hemp agro-industrial and biopharma markets with a diversified product offering and expanding geographic presence.